NCT02531607View on ClinicalTrials.gov

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

Active, not recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

November 13, 2014

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

Pancreatic Neoplasms

Interventions

OTHER

blood and bile

20ml of blood will be obtained from consented participants. 5ml of bile will be collected during the endoscopic procedure.

Trial Locations (1)

32803

AdventHealth, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AdventHealth

OTHER